| 10-Q | 2020-03-31 | Filed 2020-05-08 |
| 10-K | 2019-12-31 | Filed 2020-03-10 |
| 10-Q | 2019-09-30 | Filed 2019-11-12 |
| 10-Q | 2019-06-30 | Filed 2019-08-09 |
| 10-Q | 2019-03-31 | Filed 2019-05-09 |
| 10-K | 2018-12-31 | Filed 2019-03-13 |
| 10-Q | 2018-09-30 | Filed 2018-11-08 |
| 10-Q | 2018-06-30 | Filed 2018-08-09 |
| 10-Q | 2018-03-31 | Filed 2018-05-03 |
| 10-K | 2017-12-31 | Filed 2018-03-08 |
| 10-Q | 2017-09-30 | Filed 2017-11-02 |
| 10-Q | 2017-06-30 | Filed 2017-08-09 |
| 10-Q | 2017-03-31 | Filed 2017-05-04 |
| 10-Q | 2016-09-30 | Filed 2016-11-14 |
| 10-Q | 2016-06-30 | Filed 2016-08-15 |
| 10-K | 2016-03-31 | Filed 2016-06-28 |
| 10-Q | 2015-12-31 | Filed 2016-02-11 |
| 10-Q | 2015-09-30 | Filed 2015-11-16 |
| 10-Q | 2015-06-30 | Filed 2015-08-06 |
| 10-K | 2015-03-31 | Filed 2015-05-19 |
| 10-Q | 2014-12-31 | Filed 2015-02-05 |
| 10-Q | 2014-09-30 | Filed 2014-11-12 |
| 10-Q | 2014-06-30 | Filed 2014-07-31 |
| 10-K | 2014-03-31 | Filed 2014-06-25 |
| 10-Q | 2013-12-31 | Filed 2014-02-13 |
| 10-Q | 2013-09-30 | Filed 2013-11-18 |
| 10-Q | 2013-06-30 | Filed 2013-08-14 |
| 10-K | 2013-03-31 | Filed 2013-06-25 |
| 10-Q | 2012-12-31 | Filed 2013-02-14 |
| 10-Q | 2012-09-30 | Filed 2012-11-09 |
| 10-Q | 2012-06-30 | Filed 2012-08-14 |
| 10-K | 2012-03-31 | Filed 2012-06-27 |
| 10-Q | 2011-12-31 | Filed 2012-02-21 |
| 10-Q | 2011-09-30 | Filed 2011-11-14 |
| 10-Q | 2011-06-30 | Filed 2011-08-15 |
| 10-K | 2011-03-31 | Filed 2011-06-27 |
| 10-Q | 2010-12-31 | Filed 2011-02-22 |
| 10-Q | 2010-09-30 | Filed 2010-11-09 |
| 10-Q | 2010-06-30 | Filed 2010-08-23 |
| 10-K | 2010-03-31 | Filed 2010-06-22 |
| 10-Q | 2009-12-31 | Filed 2010-02-16 |
| 8-K | 2020-05-19 | Regulation FD, Other Events, Exhibits |
| 8-K | 2020-05-07 | Earnings, Exhibits |
| 8-K | 2020-05-01 | Shareholder Vote |
| 8-K | 2020-03-05 | Earnings, Exhibits |
| 8-K | 2020-01-09 | Earnings, Exhibits |
| 8-K | 2019-12-14 | Sale of Shares |
| 8-K | 2019-11-07 | Earnings, Exhibits |
| 8-K | 2019-10-28 | Officers, Exhibits |
| 8-K | 2019-10-09 | Other Events, Exhibits |
| 8-K | 2019-08-15 | Accountant, Exhibits |
| 8-K | 2019-08-08 | Earnings, Exhibits |
| 8-K | 2019-07-09 | Enter Agreement, Exhibits |
| 8-K | 2019-06-19 | Other Events, Exhibits |
| 8-K | 2019-05-14 | Enter Agreement, M&A, Regulation FD, Exhibits |
| 8-K | 2019-05-02 | Earnings, Exhibits |
| 8-K | 2019-05-02 | Shareholder Vote |
| 8-K | 2019-03-07 | Earnings, Exhibits |
| 8-K | 2019-01-04 | Officers, Exhibits |
| 8-K | 2018-12-14 | Enter Agreement, Off-BS Arrangement, Sale of Shares, Other Events, Exhibits |
| 8-K | 2018-08-24 | Enter Agreement, Exhibits |
| 8-K | 2018-05-17 | Shareholder Vote |
| 8-K | 2018-03-28 | Officers, Exhibits |
| 8-K | 2018-03-06 | Earnings, Exhibits |
| 8-K | 2018-02-08 | Other Events |
| 8-K | 2018-01-02 | Regulation FD |
Cryoport is a life sciences services company focused on providing critical solutions, such as temperature controlled logistics, bioservices and end-product fulfillment to the biopharma, reproductive medicine and animal health markets. Our differentiated products and services enable our clients to ship, store and deliver biologics and other life sciences commodities in a continual temperature controlled state, including ultra-low cryogenic and other temperature ranges.
Cryoport's advanced, comprehensive and technology-centric systems and solutions were designed to support the global high-volume distribution of commercial biologic and cell based products regulated by the United States Food and Drug Administration (FDA) and other international regulatory bodies for distribution in the Americas, EMEA (Europe, the Middle East, and Africa) and APAC (Asia-Pacific) regions. Cryoport's solutions are also designed to support pre-clinical, clinical trials, Biologics License Applications (BLA), Investigational New Drug Applications (IND) and New Drug Applications (NDA) with the FDA as well global clinical trials initiated in other countries, where strict regulatory compliance and quality assurance is mandated. Our industry standard setting Chain of ComplianceTM solution, which includes vital analytics, such as ‘chain-of-condition' and ‘chain-of-custody' information in a single data stream, empowers our clients' continuous vigilance over their commodities. In addition, our Chain of ComplianceTM standard ensures full traceability of the equipment used and the processes employed, further supporting each client's goal to minimize risk and maximize success of their new biologics or other commodities as they are introduced into the global markets.
As part of our services, our technologies provide the ability for Cryoport personnel and our clients to monitor conditions of the internal shipping environment, location and other specified critical variables for each shipment in near real time. In accordance with client requirements, information is recorded and archived for each shipment for scientific, quality assurance and regulatory purposes in a secure cloud-based system that can be accessed globally. This information provides an audit trail that can verify the in-shipment condition in which the life sciences commodity, material, product, vaccine or therapy was shipped and/or stored.
| Comps ($'000 TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CH Robinson Worldwide (CHRW) | 11,635,786 | 0% | 14.2 | 14% | 4,636,549 | 2,963,453 | 15,654,090 | 0 | 665,012 | 878,507 | 12,504,453 |
| Brinks (BCO) | 4,288,312 | 17% | 15.1 | 2% | 3,702,600 | 3,517,400 | 3,655,100 | 621,800 | 70,100 | 372,600 | 5,612,012 |
| Macquarie Infrastructure (MIC) | 3,363,346 | 0% | 11.5 | 2% | 6,924,000 | 4,041,000 | 1,740,757 | 0 | 142,000 | 488,000 | 5,613,346 |
| World Fuel Services (INT) | 2,606,636 | 3% | 9.1 | 3% | 5,797,500 | 3,938,900 | 37,449,500 | 1,087,600 | 154,100 | 337,200 | 3,075,536 |
| Forward Air (FWRD) | 1,812,041 | 41% | 12.7 | 9% | 980,633 | 419,488 | 1,385,452 | 566,147 | 90,616 | 145,692 | 1,849,955 |
| Hub Group (HUBG) | 1,542,347 | 14% | 8.0 | 7% | 1,910,683 | 866,127 | 3,785,729 | 533,797 | 128,127 | 218,743 | 1,740,913 |
| Echo Global Logistics (ECHO) | 622,442 | 13% | 13.5 | 2% | 847,266 | 464,218 | 2,236,277 | 296,349 | 20,342 | 55,740 | 750,852 |
| Cryoport (CYRX) | 605,039 | 50% | -29.9 | -15% | 135,058 | 24,729 | 30,391 | 15,235 | -19,642 | -17,120 | 511,536 |
| Roadrunner Transportation Systems (RRTS) | 359,858 | 0% | -2.7 | -34% | 793,204 | 666,350 | 1,446,983 | 0 | -266,699 | -207,347 | 552,102 |
| Radiant Logistics (RLGT) | 273,083 | 26% | 7.1 | 6% | 293,077 | 162,562 | 872,178 | 230,766 | 17,305 | 42,562 | 303,658 |
| Adams Resources & Energy (AE) | 126,292 | 0% | -0.2 | 1% | 313,845 | 163,964 | 1,822,557 | 0 | 1,706 | 16,049 | -3,337 |
| Hunter Maritime Acquisition (HUNT) | 10,861,299 | 0% | 182,885 | 36,848 | 0 | 0 | 0 | 0 | 10,836,241 | ||
| Sino-Global Shipping America (SINO) | 12,661 | 16% | -2.3 | -36% | 18,690 | 5,139 | 35,075 | 5,452 | -6,793 | -5,527 | 12,519 |
| CrossAmerica Partners (CAPL) | 8% | 6.1 | 2% | 919,061 | 827,269 | 2,184,292 | 164,666 | 21,501 | 85,724 | 521,834 | |
| NGL Energy Partners (NGL) | 4% | 7.3 | -0% | 6,664,023 | 4,669,629 | 22,445,066 | 854,989 | -19,842 | 378,368 | 2,773,311 | |
| Sunoco (SUN) | 6% | 10.4 | 3% | 5,497,000 | 4,735,000 | 16,375,000 | 931,000 | 158,000 | 297,000 | 3,087,000 | |
| Global Partners (GLP) | 6% | -0.1 | 3% | 2,678,245 | 2,196,498 | 13,007,120 | 733,600 | 89,225 | 90,500 | -5,780 | |
| Sprague Resources (SRLP) | 6% | -0.1 | 6% | 970,183 | 875,423 | 3,582,790 | 200,724 | 55,936 | 121,373 | -6,946 | |
| Martin Midstream Partners (MMLP) | 31% | -4.6 | -26% | 691,131 | 724,501 | 869,023 | 269,458 | -182,501 | -131,851 | 604,491 | |
| Genesis Energy (GEL) | 0% | 5.6 | 1% | 6,560,681 | 4,218,997 | 2,565,787 | 0 | 50,630 | 437,199 | 2,443,391 |